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Background
We focused our study on patients with severe compro-
mised ischemic left ventricle and functional mitral
regurgitation to understand how mitral valve replace-
ment versus repair affects survival and provide the pre-
dictors of hospital and long-term mortality.
Methods
870 patients (mean age, 57,9±8,3 years) from 2000 to
2012, with coronary artery diseases and significant
ischemic mitral regurgitation (>2) were operated – in
787pts CABG+MV repair were performed and in 83 pts
MV replacement were combined with CABG. Groups
were matched by propensity score using demographics
dates, co-morbidity, LV remodeling and MR grade by
quantitative echocardiography. Survival (with mean fol-
low-up 5,3 ± 1,6 years) and NYHA functional class were
compared. The impact of mitral valve replacement ver-
sus repair on survival by comparing theses propensity
matched subgroups was analyzed.
Results
Follow-up was 100% complete. Before matching 10-year
survival was significantly worse in replacement group
(long-rank p=0,003). After propensity matching 1:2
we’ve received homogenous cohort of 99 pts with severe
compromised LV (EDD 71,8 ± 7,6 mm, ESD 59 ± 8,1
mm, iEDV 131 ± 28,1 ml/m2 with EF 31,3 ± 3,7%) and
severe MR. The fact of mitral valve replacement versus
repair did not influence survival (long-rank p = 0,443)
and overall in 1- and 5-year it were 91,8±0,14% and
69,2 ± 0,48% respectively. The independent risk factors
for an increased mortality within the five years of surgery
in multivariate propensity-matched analyses were found
LV ESD (HR–1,085, 95% CI 1,018–1,157, p=0,013),
chronic renal disease (HR–1,8, 95% CI 1,34–2,45 p =
0,012), use of IABP during hospital period (HR–3,147,
95% CI 1,17–8,4, p = 0,022) and age (HR–0,936, 95% CI
0,876–1,0, p = 0,011).
Conclusion
The mitral valve replacement versus repair did not seem
to affect survival in patients with severe damaged
ischemic LV and it mostly depends on factors related to
the patient’s condition at the time of surgery.
Published: 11 September 2013
doi:10.1186/1749-8090-8-S1-O213
Cite this article as: Shumavets et al.: Repair or replace the mitral valve
for severe ischemic mitral regurgitation? Journal of Cardiothoracic Surgery
2013 8(Suppl 1):O213.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit* Correspondence: vshumaviec@gmail.com
Cardiac Surgery Department, Belarus Cardiology Centre, Minsk, Belarus
Shumavets et al. Journal of Cardiothoracic Surgery 2013, 8(Suppl 1):O213
http://www.cardiothoracicsurgery.org/content/8/S1/O213
© 2013 Shumavets et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
